Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Entinostat

EU orphan designation number: EU/3/10/732   
Active ingredient: Entinostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Ockham Europe Limited
Roslin Biocentre, Roslin, Midlothian, Edinburgh EH25 9TT, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Centralised Orphan - Designation EMEA/OD/150/09 (2010)3901 of 10/06/2010
12/02/2013 Other procedure